|
COURSE DESCRIPTION
Release Date: April 26, 2007
Expiration Date: April 26, 2008
Program Overview
This Web cast is a video of a dinner meeting held in Atlanta, Georgia on March 21, 2007. Experts in the field of cancer and chemotherapy complications review the association of management of treatment induced effects to the survival of patients with head and neck cancer. New directions and guidelines for the use of red cell growth factors are discussed in detail and very recent data are reviewed.
Target Audience
This
educational
activity
is
designed
for
medical
oncologists,
internal
medicine
specialists,
other
physicians
and
physicians
in
training,
nurses,
and
pharmacists
involved
in
the
care
of
patients
with
cancer
and
who
manage
complications
of
cancer
therapy.
No
specific
knowledge
other
than
a
general
understanding
of
medicine
is
required
for
successful
participation
in
this
educational
activity.
Educational Objectives
After
successfully
completing
this
continuing
medical
education
program,
participants
should
be
able
to:
- Understand
the
etiology
and
factors
affecting
the
development
of
common
serious
complications
of
cancer
therapy,
including
mucositis,
neutropenia,
and
chemotherapy-related
bone
loss
- Evaluate
patients
with
cancer
for
the
development
of
mucositis
and
neutropenia
and
initiate
appropriate
prophylactic
and
preemptive
measures
-
Understand
the
mechanism
of
action,
indications,
and
administration
of
new
agents
for
the
treatment
of
mucositis,
neutropenia
and
chemotherapy-related
bone
loss
in
cancer
patients
with
hematologic
and
solid
tumors
-
Appropriately
assess
cancer
patients
for
chemotherapy-induced
bone
loss
and
institute
appropriate
treatment
Continuing
Medical
Education
For
US
Physicians
Imedex®,
Inc.
is
accredited
by
the
Accreditation
Council
for
Continuing
Medical
Education
to
provide
continuing
medical
education
for
physicians.
Imedex,
Inc.
designates
this
educational
activity
for
a
maximum
1.75
AMA
PRA
Category
1
Credits™.
Physicians
should
only
claim
credit
commensurate
with
the
extent
of
their
participation
in
the
activity
For
Nurses
This
program,
file
number
0407I,
has
been
approved
by
an
AACN
Certification
Corporation-approved
provider
(Provider
#
00013328)
under
established
AACN
Certification
Corporation
guidelines
for
a
maximum
of
1.5
contact
hours,
CERP
Category
A.
Credits
will
be
awarded
upon
completion
and
submission
of
the
self-assessment
questions,
evaluation
form,
and
CME
credit
request
form
to:
Imedex,
Inc.
4325
Alexander
Drive
Alpharetta,
GA
30022
Fax:
+1(770)
751
7334
Deadline
for
CME
Credit
submission:
April
26,
2008
Unapproved
and
Investigational
Uses
of
Drugs
and
Devices
This
Web
cast
may
contain
information
about
experimental
and
other
uses
of
drugs
or
devices
that
are
not
currently
approved
by
the
US
Food
and
Drug
Administration
(FDA)
and/or
other
national
regulatory
agencies
in
the
United
States
and
other
countries.
Participants
in
the
United
States
are
encouraged
to
consult
the
FDA-approved
product
labeling
for
any
drug
or
device
mentioned
in
this
program
before
use.
Participants
from
other
countries
should
consult
with
their
respective
regulatory
authorities.
The
opinions
expressed
in
this
Web
cast
are
the
opinions
of
the
authors
and
do
not
necessarily
reflect
the
opinions
of
Imedex,
Inc.
or
Amgen,
Inc.
Disclosure
of
Financial
Interests
As
an
accredited
provider
of
continuing
medical
education,
Imedex,
Inc.
is
required
to
ask
speakers
to
disclose
any
real
or
apparent
conflict
of
interest
they
may
have
as
related
to
the
contents
of
their
presentation(s).
The
existence
of
commercial
or
financial
interests
of
speakers
related
to
the
subject
matter
of
their
presentation(s)
should
not
be
construed
as
implying
bias
or
decreasing
the
value
of
their
presentation(s).
However,
disclosure
should
help
participants
form
their
own
judgments.
All
speakers
were
independently
selected
by
the
organizing
committee.
Those
speakers
who
disclosed
affiliations
or
financial
interests
with
the
commercial
organizations
involved
with
products,
to
which
they
may
refer,
are
listed
below.
1=grant/research
support
2=consultant
3=speaker’s
bureau
4=stock
shareholder
5=other
support
Rodolfo
Bordoni,
MD
-
Ortho
Biotech,
Products,
L.P.
3
The following speakers have reported an affiliation with the supporters of this conference:
Rodolfo
Bordoni,
MD
-
Amgen,
Inc.
3
The
following
speakers
did
not
report
any
affiliation:
Barbara Murphy, MD
Edith A. Perez, MD
Imedex,
Inc.
is
an
independent
provider
of
continuing
medical
education.
Imedex,
Inc.
has
no
proprietary
or
financial
interest
in
medical
or
healthcare
products
over
which
the
FDA
has
regulatory
authority.
Imedex,
Inc.
Staff
Disclosure
of
Financial
Relationships
All
Imedex,
Inc.
staff
members
who
are
in
a
position
to
control
the
content
of
this
activity
have
no
financial
relationships
with
any
commercial
interests
that
are
relevant
to
this
activity.
Event
Organizer
Imedex,
Inc.
4325
Alexander
Drive
Alpharetta,
GA
30022
Fax:
+1(770)
751
7334
Systems
Requirements
- Windows
98/NT/2000/XP/Vista
or
Mac
OS
9/X
- Internet
Browser
(Microsoft
Internet
Explorer
5.5
or
later,
Firefox,
Netscape,
Safari,
etc.)
- Adobe
Flash
player
8
-
Click
here
to
download
- High-speed
Internet
connection
- Monitor
settings:
High
color
at
800
x
600
pixels
- Sound
card
and
speakers
- Evaluation
forms
require
Adobe
Acrobat
Reader
-
Click
here
to
download
©2007
Imedex®,
Inc.
All
rights
reserved.
Reproduction
in
whole
or
part
is
prohibited
without
prior
written
consent
from
Imedex
and
contributing
faculty.
|
